Kent and Medway Cancer Alliance brings together clinicians and managers from health, social care and other services to transform the diagnosis, treatment and care for cancer patients.
These partnerships enable care to be more effectively planned across local cancer pathways. The alliance is made up of many stakeholders, including:
- healthcare providers from across Kent and Medway (acute and community providers, primary care)
- health service commissioners (clinical commissioning groups)
- NHS England and NHS Improvement
- patient representatives
- voluntary and charitable organisations (such as Macmillan, Cancer Research UK)
- National Institute for Health Research
- Public Health
- Integrated Care Partnership representation
- Integrated Care System representation
It also has strong links with neighbouring cancer alliances in south east London, Surrey and Sussex.
It is aligned to and working within the Integrated Care System (ICS) in Kent and Medway. The alliance also works closely with:
NHS Kent and Medway Clinical Commissioning Group, which plans, buys and monitors health services in Kent and Medway
- Kent and Medway Cancer Collaborative, which is a collection of organisations, services and stakeholders working together to increase cancer survival
- Kent and Medway Cancer Action Partnership, which works to involve patients in service development. The alliance is committed to involving patients and service users in its plans to improve cancer care across the county and to make sure their voices are heard.
Kent and Medway Cancer Alliance is led by:
- Miles Scott, Executive Cancer Lead and Chief Executive of Maidstone and Tunbridge Wells NHS Trust
- Dr Henry Taylor, Clinical Lead and Clinical Oncologist at the Kent Oncology Centre
- Ian Vousden, Kent and Medway Cancer Alliance Programme Director.